speb/financial-data huggingface dataset:
NICN.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 0.00
NICN.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
NICN.V balance_sheet (quarterly, 2025-09-30) — Working Capital: 127055.00
NICN.V income_statement (annual, 2025-12-31) — +Operating Expense: 1945343.00
NICN.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 1391135.00
NICN.V income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
NICN.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
NICN.V balance_sheet (annual, 2025-12-31) — Accounts Payable: 736655.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 736655.00
NICN.V balance_sheet (annual, 2025-12-31) — Accounts Receivable: 84344.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 84344.00
NICN.V income_statement (annual, 2025-12-31) — Basic Average Shares: 88092345.00
NICN.V income_statement (annual, 2025-12-31) — Basic EPS: -0.02
NICN.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 974493.00
NICN.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 522061.00
NICN.V balance_sheet (annual, 2025-12-31) — Capital Stock: 11402529.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 11402529.00
NICN.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1190486.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1190486.00
NICN.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1190486.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1190486.00
NICN.V balance_sheet (annual, 2025-12-31) — Cash Financial: 1190486.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 1190486.00
NICN.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1429200.00
NICN.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1429200.00
NICN.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1213207.00
NICN.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -760775.00
NICN.V cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 807598.00
NICN.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 752977.00
NICN.V cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -21808.00
NICN.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -41825.00
NICN.V cash_flow (annual, 2025-12-31) — Change In Receivables: -69085.00
NICN.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -84344.00
NICN.V cash_flow (annual, 2025-12-31) — Change In Working Capital: 716705.00
NICN.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 626808.00
NICN.V cash_flow (annual, 2025-12-31) — Changes In Cash: 215993.00
NICN.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: 668425.00
NICN.V balance_sheet (annual, 2025-12-31) — Common Stock: 11402529.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 11402529.00
NICN.V balance_sheet (annual, 2025-12-31) — Common Stock Equity: 311052.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 311052.00
NICN.V cash_flow (annual, 2025-12-31) — Common Stock Issuance: 1500000.00
NICN.V cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 1500000.00
NICN.V balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 282758.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 282758.00
NICN.V balance_sheet (annual, 2025-12-31) — Current Assets: 1330465.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 1330465.00
NICN.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 1019413.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1019413.00
NICN.V income_statement (annual, 2025-12-31) — Diluted Average Shares: 88092345.00
NICN.V income_statement (annual, 2025-12-31) — Diluted EPS: -0.02
NICN.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -1734675.00
NICN.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1245203.00
NICN.V income_statement (annual, 2025-12-31) — EBIT: -1945343.00
NICN.V income_statement (quarterly, 2025-12-31) — EBIT: -1391135.00
NICN.V income_statement (annual, 2025-12-31) — EBITDA: -1945343.00
NICN.V income_statement (quarterly, 2025-12-31) — EBITDA: -1391135.00
NICN.V cash_flow (annual, 2025-12-31) — End Cash Position: 1190486.00
NICN.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 1190486.00
NICN.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: 1429200.00
NICN.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 1429200.00
NICN.V cash_flow (annual, 2025-12-31) — Free Cash Flow: -1213207.00
NICN.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -760775.00
NICN.V income_statement (annual, 2025-12-31) — General And Administrative Expense: 668684.00
NICN.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 382295.00
NICN.V income_statement (annual, 2025-12-31) — Interest Income: 15431.00
NICN.V income_statement (quarterly, 2025-12-31) — Interest Income: 3552.00
NICN.V income_statement (annual, 2025-12-31) — Interest Income Non Operating: 15431.00
NICN.V income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 3552.00
NICN.V balance_sheet (annual, 2025-12-31) — Invested Capital: 311052.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 311052.00
NICN.V cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 1500000.00
NICN.V cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 1500000.00
NICN.V cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 1500000.00
NICN.V cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 1500000.00
NICN.V income_statement (annual, 2025-12-31) — Net Income: -1734675.00
NICN.V income_statement (quarterly, 2025-12-31) — Net Income: -1245203.00
NICN.V income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -1734675.00
NICN.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1245203.00
NICN.V income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -1734675.00
NICN.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -1245203.00
NICN.V income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1734675.00
NICN.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1245203.00
NICN.V income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1734675.00
NICN.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1245203.00
NICN.V cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -1734675.00
NICN.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -1245203.00
NICN.V income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -1734675.00
NICN.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -1245203.00
NICN.V income_statement (annual, 2025-12-31) — Net Interest Income: 15431.00
NICN.V income_statement (quarterly, 2025-12-31) — Net Interest Income: 3552.00
NICN.V income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 15431.00
NICN.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 3552.00
NICN.V cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -70800.00
NICN.V balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 311052.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 311052.00
NICN.V income_statement (annual, 2025-12-31) — Normalized EBITDA: -1945343.00
NICN.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -1391135.00
NICN.V income_statement (annual, 2025-12-31) — Normalized Income: -1734675.00
NICN.V income_statement (quarterly, 2025-12-31) — Normalized Income: -1245203.00
NICN.V cash_flow (annual, 2025-12-31) — Operating Cash Flow: -1213207.00
NICN.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -760775.00
NICN.V income_statement (annual, 2025-12-31) — Operating Income: -1945343.00
NICN.V income_statement (quarterly, 2025-12-31) — Operating Income: -1391135.00
NICN.V income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
NICN.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
NICN.V balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 111698902.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 111698902.00
NICN.V balance_sheet (annual, 2025-12-31) — Other Equity Interest: 599249.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 599249.00
NICN.V income_statement (annual, 2025-12-31) — Other Gand A: 484364.00
NICN.V income_statement (quarterly, 2025-12-31) — Other Gand A: 302849.00
NICN.V income_statement (annual, 2025-12-31) — Other Income Expense: 195237.00
NICN.V income_statement (quarterly, 2025-12-31) — Other Income Expense: 142380.00
NICN.V cash_flow (annual, 2025-12-31) — Other Non Cash Items: -195237.00
NICN.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -142380.00
NICN.V income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 195237.00
NICN.V income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 142380.00
NICN.V income_statement (annual, 2025-12-31) — Other Operating Expenses: 1200295.00
NICN.V income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 977796.00
NICN.V balance_sheet (annual, 2025-12-31) — Payables: 736655.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Payables: 736655.00
NICN.V balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1019413.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1019413.00
NICN.V balance_sheet (annual, 2025-12-31) — Prepaid Assets: 55635.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 55635.00
NICN.V income_statement (annual, 2025-12-31) — Pretax Income: -1734675.00
NICN.V income_statement (quarterly, 2025-12-31) — Pretax Income: -1245203.00
NICN.V balance_sheet (annual, 2025-12-31) — Receivables: 84344.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Receivables: 84344.00
NICN.V income_statement (annual, 2025-12-31) — Rent And Landing Fees: 56446.00
NICN.V income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 56446.00
NICN.V balance_sheet (annual, 2025-12-31) — Retained Earnings: -11690726.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -11690726.00
NICN.V income_statement (annual, 2025-12-31) — Salaries And Wages: 127874.00
NICN.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 23000.00
NICN.V income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 76364.00
NICN.V income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 31044.00
NICN.V income_statement (annual, 2025-12-31) — Selling General And Administration: 745048.00
NICN.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 413339.00
NICN.V balance_sheet (annual, 2025-12-31) — Share Issued: 111698902.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 111698902.00
NICN.V cash_flow (annual, 2025-12-31) — Stock Based Compensation: 0.00
NICN.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 0.00
NICN.V balance_sheet (annual, 2025-12-31) — Stockholders Equity: 311052.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 311052.00
NICN.V balance_sheet (annual, 2025-12-31) — Tangible Book Value: 311052.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 311052.00
NICN.V income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NICN.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NICN.V income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
NICN.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
NICN.V balance_sheet (annual, 2025-12-31) — Total Assets: 1330465.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 1330465.00
NICN.V balance_sheet (annual, 2025-12-31) — Total Capitalization: 311052.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 311052.00
NICN.V balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 311052.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 311052.00
NICN.V income_statement (annual, 2025-12-31) — Total Expenses: 1945343.00
NICN.V income_statement (quarterly, 2025-12-31) — Total Expenses: 1391135.00
NICN.V balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1019413.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1019413.00
NICN.V balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 0.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 0.00
NICN.V balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
NICN.V balance_sheet (annual, 2025-12-31) — Working Capital: 311052.00
NICN.V balance_sheet (quarterly, 2025-12-31) — Working Capital: 311052.00
NICN.V income_statement (quarterly, 2026-03-31) — +Operating Expense: 731188.00
NICN.V income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 502173.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 72667.00
NICN.V income_statement (quarterly, 2026-03-31) — Basic Average Shares: 116173144.00
NICN.V income_statement (quarterly, 2026-03-31) — Basic EPS: -0.01
NICN.V cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1190486.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Capital Stock: 12354679.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1584198.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1584198.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Cash Financial: 1584198.00
NICN.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 1327150.00
NICN.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -933438.00
NICN.V cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -208433.00
NICN.V cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -7921.00
NICN.V cash_flow (quarterly, 2026-03-31) — Change In Receivables: 11677.00
NICN.V cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -204677.00
NICN.V cash_flow (quarterly, 2026-03-31) — Changes In Cash: 393712.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Common Stock: 12354679.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 592454.00
NICN.V cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 1270000.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 308807.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Current Assets: 1720421.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1127967.00
NICN.V income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 116173144.00
NICN.V income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.01
NICN.V income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -670748.00
NICN.V income_statement (quarterly, 2026-03-31) — EBIT: -731188.00
NICN.V income_statement (quarterly, 2026-03-31) — EBITDA: -731188.00
NICN.V cash_flow (quarterly, 2026-03-31) — End Cash Position: 1584198.00
NICN.V cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 1327150.00
NICN.V cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -933438.00
NICN.V income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 115900.00
NICN.V income_statement (quarterly, 2026-03-31) — Interest Income: 2427.00
NICN.V income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 2427.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Invested Capital: 592454.00
NICN.V cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 1270000.00
NICN.V cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 1270000.00
NICN.V income_statement (quarterly, 2026-03-31) — Net Income: -670748.00
NICN.V income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -670748.00
NICN.V income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -670748.00
NICN.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -670748.00
NICN.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -670748.00
NICN.V cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -670748.00
NICN.V income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -670748.00
NICN.V income_statement (quarterly, 2026-03-31) — Net Interest Income: 2427.00
NICN.V income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 2427.00
NICN.V cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -10650.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 592454.00
NICN.V income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -731188.00
NICN.V income_statement (quarterly, 2026-03-31) — Normalized Income: -670748.00
NICN.V cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -933438.00
NICN.V income_statement (quarterly, 2026-03-31) — Operating Income: -731188.00
NICN.V income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 130734902.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 316987.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 599249.00
NICN.V income_statement (quarterly, 2026-03-31) — Other Gand A: 95400.00
NICN.V income_statement (quarterly, 2026-03-31) — Other Income Expense: 58013.00
NICN.V cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -58013.00
NICN.V income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 58013.00
NICN.V income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 601952.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Payables: 502173.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 810980.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 63556.00
NICN.V income_statement (quarterly, 2026-03-31) — Pretax Income: -670748.00
NICN.V cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 67800.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Receivables: 72667.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -12361474.00
NICN.V income_statement (quarterly, 2026-03-31) — Salaries And Wages: 20500.00
NICN.V income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 13336.00
NICN.V income_statement (quarterly, 2026-03-31) — Selling General And Administration: 129236.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Share Issued: 130734902.00
NICN.V cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 0.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 592454.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 592454.00
NICN.V income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
NICN.V income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Total Assets: 1720421.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 592454.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 592454.00
NICN.V income_statement (quarterly, 2026-03-31) — Total Expenses: 731188.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1127967.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 0.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
NICN.V balance_sheet (quarterly, 2026-03-31) — Working Capital: 592454.00
NICU.V cash_flow (annual, 2021-12-31) — Change In Payables And Accrued Expense: -9786.00
NICU.V cash_flow (annual, 2021-12-31) — Change In Prepaid Assets: 23196.00
NICU.V cash_flow (annual, 2021-12-31) — Change In Receivables: -438067.00
NICU.V cash_flow (annual, 2021-12-31) — Change In Working Capital: -424657.00
NICU.V cash_flow (annual, 2021-12-31) — Changes In Account Receivables: -438067.00
NICU.V balance_sheet (annual, 2021-12-31) — Current Debt: 28708.00
NICU.V cash_flow (annual, 2021-12-31) — Depreciation: 15823.00
NICU.V cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 15823.00
NICU.V cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 0.00
NICU.V income_statement (annual, 2021-12-31) — Interest Income: 1811.00
NICU.V income_statement (annual, 2021-12-31) — Interest Income Non Operating: 1811.00
NICU.V cash_flow (annual, 2021-12-31) — Interest Paid Supplemental Data: 0.00
NICU.V balance_sheet (annual, 2021-12-31) — Line Of Credit: 28708.00
NICU.V balance_sheet (annual, 2021-12-31) — Long Term Debt: 28708.00
NICU.V cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -13191.00
NICU.V balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 16704.00
NICU.V cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 75441.00
NICU.V cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: -270.00
NICU.V cash_flow (annual, 2021-12-31) — Net Other Financing Charges: 128174.00
NICU.V cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 282500.00
NICU.V cash_flow (annual, 2021-12-31) — Operating Gains Losses: -270.00
NICU.V balance_sheet (annual, 2021-12-31) — Other Payable: 332704.00
NICU.V balance_sheet (annual, 2021-12-31) — Other Properties: 114970.00
NICU.V cash_flow (annual, 2021-12-31) — Repayment Of Debt: -13191.00
NICU.V cash_flow (annual, 2021-12-31) — Sale Of Business: 75441.00
NICU.V income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 133366.00
NICU.V income_statement (annual, 2022-12-31) — +Operating Expense: 22275962.00
NICU.V income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
NICU.V balance_sheet (annual, 2022-12-31) — Accounts Payable: 979015.00
NICU.V balance_sheet (annual, 2022-12-31) — Accounts Receivable: 622077.00
NICU.V balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -61057.00
NICU.V income_statement (annual, 2022-12-31) — Basic Average Shares: 83666459.00
NICU.V income_statement (annual, 2022-12-31) — Basic EPS: -0.26
NICU.V cash_flow (annual, 2022-12-31) — Beginning Cash Position: 5682332.00
NICU.V cash_flow (annual, 2022-12-31) — Capital Expenditure: -316897.00
NICU.V balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 30865.00
NICU.V balance_sheet (annual, 2022-12-31) — Capital Stock: 32466633.00
NICU.V balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 6175126.00
NICU.V balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 6175126.00
NICU.V balance_sheet (annual, 2022-12-31) — Cash Financial: 6175126.00
NICU.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 18967605.00
NICU.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -307012.00
NICU.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -18167799.00
NICU.V cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 778703.00
NICU.V cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -62425.00
NICU.V cash_flow (annual, 2022-12-31) — Change In Receivables: -108354.00
NICU.V cash_flow (annual, 2022-12-31) — Change In Working Capital: 607924.00
NICU.V cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -108354.00
NICU.V cash_flow (annual, 2022-12-31) — Changes In Cash: 492794.00
NICU.V balance_sheet (annual, 2022-12-31) — Common Stock: 32466633.00
NICU.V balance_sheet (annual, 2022-12-31) — Common Stock Equity: 19999083.00
NICU.V cash_flow (annual, 2022-12-31) — Common Stock Issuance: 18765959.00
NICU.V income_statement (annual, 2022-12-31) — Cost Of Revenue: 32443.00
NICU.V balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 672579.00
NICU.V balance_sheet (annual, 2022-12-31) — Current Assets: 6905150.00
NICU.V balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 21195.00
NICU.V balance_sheet (annual, 2022-12-31) — Current Debt: 30000.00
NICU.V balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 51195.00
NICU.V balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 2645375.00
NICU.V balance_sheet (annual, 2022-12-31) — Current Liabilities: 4348164.00
NICU.V cash_flow (annual, 2022-12-31) — Depreciation: 32443.00
NICU.V cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 32443.00
NICU.V cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 32443.00
NICU.V income_statement (annual, 2022-12-31) — Diluted Average Shares: 83666459.00
NICU.V income_statement (annual, 2022-12-31) — Diluted EPS: -0.26
NICU.V income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -21969580.00
NICU.V income_statement (annual, 2022-12-31) — EBIT: -21904766.00
NICU.V income_statement (annual, 2022-12-31) — EBITDA: -21872323.00
NICU.V cash_flow (annual, 2022-12-31) — End Cash Position: 6175126.00
NICU.V cash_flow (annual, 2022-12-31) — Financing Cash Flow: 18967605.00
NICU.V cash_flow (annual, 2022-12-31) — Free Cash Flow: -18484696.00
NICU.V income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 1504.00
NICU.V income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -27558.00
NICU.V income_statement (annual, 2022-12-31) — General And Administrative Expense: 2179900.00
NICU.V balance_sheet (annual, 2022-12-31) — Gross PPE: 17562191.00
NICU.V income_statement (annual, 2022-12-31) — Gross Profit: -32443.00
NICU.V cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 0.00
NICU.V income_statement (annual, 2022-12-31) — Interest Expense: 64814.00
NICU.V income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 64814.00
NICU.V income_statement (annual, 2022-12-31) — Interest Income: 96989.00
NICU.V income_statement (annual, 2022-12-31) — Interest Income Non Operating: 96989.00
NICU.V cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 0.00
NICU.V balance_sheet (annual, 2022-12-31) — Invested Capital: 20029083.00
NICU.V cash_flow (annual, 2022-12-31) — Investing Cash Flow: -307012.00
NICU.V cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 18765959.00
NICU.V balance_sheet (annual, 2022-12-31) — Line Of Credit: 30000.00
NICU.V balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 9670.00
NICU.V balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 9670.00
NICU.V cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -22523.00
NICU.V balance_sheet (annual, 2022-12-31) — Long Term Provisions: 715789.00
NICU.V balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 70431.00
NICU.V cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 9885.00
NICU.V cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 18765959.00
NICU.V cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
NICU.V income_statement (annual, 2022-12-31) — Net Income: -21969580.00
NICU.V income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -21969580.00
NICU.V income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -21969580.00
NICU.V income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -21969580.00
NICU.V income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -21969580.00
NICU.V cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -21969580.00
NICU.V income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -21969580.00
NICU.V income_statement (annual, 2022-12-31) — Net Interest Income: 32175.00
NICU.V cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
NICU.V cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -22523.00
NICU.V cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -22523.00
NICU.V income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 32175.00
NICU.V balance_sheet (annual, 2022-12-31) — Net PPE: 17501134.00
NICU.V cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -316897.00
NICU.V balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 19999083.00
NICU.V income_statement (annual, 2022-12-31) — Normalized EBITDA: -21846269.00
NICU.V income_statement (annual, 2022-12-31) — Normalized Income: -21943526.00
NICU.V cash_flow (annual, 2022-12-31) — Operating Cash Flow: -18167799.00
NICU.V income_statement (annual, 2022-12-31) — Operating Income: -22308405.00
NICU.V income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
NICU.V balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 146912330.00
NICU.V balance_sheet (annual, 2022-12-31) — Other Equity Interest: 3158931.00
NICU.V income_statement (annual, 2022-12-31) — Other Gand A: 757786.00
NICU.V income_statement (annual, 2022-12-31) — Other Income Expense: 306650.00
NICU.V cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2419624.00
NICU.V balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 666422.00
NICU.V income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 332704.00
NICU.V income_statement (annual, 2022-12-31) — Other Operating Expenses: 19832580.00
NICU.V balance_sheet (annual, 2022-12-31) — Other Properties: 17491760.00
NICU.V balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 0.00
NICU.V balance_sheet (annual, 2022-12-31) — Payables: 979015.00
NICU.V balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1651594.00
NICU.V balance_sheet (annual, 2022-12-31) — Prepaid Assets: 107947.00
NICU.V income_statement (annual, 2022-12-31) — Pretax Income: -21969580.00
NICU.V cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 224169.00
NICU.V cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
NICU.V cash_flow (annual, 2022-12-31) — Purchase Of PPE: -316897.00
NICU.V balance_sheet (annual, 2022-12-31) — Receivables: 622077.00
NICU.V income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 32443.00
NICU.V income_statement (annual, 2022-12-31) — Reconciled Depreciation: 32443.00
NICU.V cash_flow (annual, 2022-12-31) — Repayment Of Debt: -22523.00
NICU.V balance_sheet (annual, 2022-12-31) — Retained Earnings: -15626481.00
NICU.V income_statement (annual, 2022-12-31) — Salaries And Wages: 1422114.00
NICU.V cash_flow (annual, 2022-12-31) — Sale Of Business: 9885.00
NICU.V income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 34996.00
NICU.V income_statement (annual, 2022-12-31) — Selling General And Administration: 2214896.00
NICU.V balance_sheet (annual, 2022-12-31) — Share Issued: 146912330.00
NICU.V income_statement (annual, 2022-12-31) — Special Income Charges: 1504.00
NICU.V cash_flow (annual, 2022-12-31) — Stock Based Compensation: 741790.00
NICU.V balance_sheet (annual, 2022-12-31) — Stockholders Equity: 19999083.00
NICU.V balance_sheet (annual, 2022-12-31) — Tangible Book Value: 19999083.00
NICU.V income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
NICU.V income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
NICU.V balance_sheet (annual, 2022-12-31) — Total Assets: 25072706.00
NICU.V balance_sheet (annual, 2022-12-31) — Total Capitalization: 19999083.00
NICU.V balance_sheet (annual, 2022-12-31) — Total Debt: 60865.00
NICU.V balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 19999083.00
NICU.V income_statement (annual, 2022-12-31) — Total Expenses: 22308405.00
NICU.V balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 5073623.00
NICU.V balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 18167556.00
NICU.V balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 725459.00
NICU.V income_statement (annual, 2022-12-31) — Total Unusual Items: -26054.00
NICU.V income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -26054.00
NICU.V balance_sheet (annual, 2022-12-31) — Working Capital: 2556986.00
NICU.V income_statement (annual, 2023-12-31) — +Operating Expense: 12555869.00
NICU.V income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
NICU.V balance_sheet (annual, 2023-12-31) — Accounts Payable: 826843.00
NICU.V balance_sheet (annual, 2023-12-31) — Accounts Receivable: 0.00
NICU.V balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -123138.00
NICU.V income_statement (annual, 2023-12-31) — Basic Average Shares: 160965300.00
NICU.V income_statement (annual, 2023-12-31) — Basic EPS: -0.06
NICU.V cash_flow (annual, 2023-12-31) — Beginning Cash Position: 6175126.00
NICU.V cash_flow (annual, 2023-12-31) — Capital Expenditure: -81773.00
NICU.V balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 42054.00
NICU.V balance_sheet (annual, 2023-12-31) — Capital Stock: 45784084.00
NICU.V balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 10890288.00
NICU.V balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 10931309.00
NICU.V balance_sheet (annual, 2023-12-31) — Cash Financial: 10890288.00
NICU.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 15372919.00
NICU.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -122023.00
NICU.V cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -10535734.00
NICU.V cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -37768.00
NICU.V cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -3363.00
NICU.V cash_flow (annual, 2023-12-31) — Change In Receivables: -268030.00
NICU.V cash_flow (annual, 2023-12-31) — Change In Working Capital: -309161.00
NICU.V cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -268030.00
NICU.V cash_flow (annual, 2023-12-31) — Changes In Cash: 4715162.00
NICU.V balance_sheet (annual, 2023-12-31) — Common Stock: 45784084.00
NICU.V balance_sheet (annual, 2023-12-31) — Common Stock Equity: 24848750.00
NICU.V cash_flow (annual, 2023-12-31) — Common Stock Issuance: 16648502.00
NICU.V income_statement (annual, 2023-12-31) — Cost Of Revenue: 62081.00
NICU.V balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 786983.00
NICU.V balance_sheet (annual, 2023-12-31) — Current Assets: 11932726.00
NICU.V balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 28452.00
NICU.V balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 28452.00
NICU.V balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 0.00
NICU.V balance_sheet (annual, 2023-12-31) — Current Liabilities: 4586875.00
NICU.V cash_flow (annual, 2023-12-31) — Depreciation: 62081.00
NICU.V cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 62081.00
NICU.V cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 62081.00
NICU.V income_statement (annual, 2023-12-31) — Diluted Average Shares: 160965300.00
NICU.V income_statement (annual, 2023-12-31) — Diluted EPS: -0.06
NICU.V income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -9721879.00
NICU.V income_statement (annual, 2023-12-31) — EBIT: -9364119.00
NICU.V income_statement (annual, 2023-12-31) — EBITDA: -9302038.00
NICU.V cash_flow (annual, 2023-12-31) — End Cash Position: 10890288.00
NICU.V cash_flow (annual, 2023-12-31) — Financing Cash Flow: 15372919.00
NICU.V cash_flow (annual, 2023-12-31) — Free Cash Flow: -10617507.00
NICU.V cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
NICU.V income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 0.00
NICU.V income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 4807.00
NICU.V income_statement (annual, 2023-12-31) — General And Administrative Expense: 4202981.00
NICU.V balance_sheet (annual, 2023-12-31) — Gross PPE: 17771903.00
NICU.V income_statement (annual, 2023-12-31) — Gross Profit: -62081.00
NICU.V cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
NICU.V income_statement (annual, 2023-12-31) — Interest Expense: 357760.00
NICU.V income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 357760.00
NICU.V income_statement (annual, 2023-12-31) — Interest Income: 856599.00
NICU.V income_statement (annual, 2023-12-31) — Interest Income Non Operating: 856599.00
NICU.V cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 0.00
NICU.V balance_sheet (annual, 2023-12-31) — Invested Capital: 24848750.00
NICU.V cash_flow (annual, 2023-12-31) — Investing Cash Flow: -122023.00
NICU.V cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 16648502.00
NICU.V balance_sheet (annual, 2023-12-31) — Line Of Credit: 0.00
NICU.V balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 13602.00
NICU.V balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 13602.00
NICU.V cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -60149.00
NICU.V balance_sheet (annual, 2023-12-31) — Long Term Provisions: 831988.00
NICU.V balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 94840.00
NICU.V cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
NICU.V cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 16648502.00
NICU.V income_statement (annual, 2023-12-31) — Net Income: -9721879.00
NICU.V income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -9721879.00
NICU.V income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -9721879.00
NICU.V income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -9721879.00
NICU.V income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -9721879.00
NICU.V cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -9721879.00
NICU.V income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -9721879.00
NICU.V income_statement (annual, 2023-12-31) — Net Interest Income: 498839.00
NICU.V cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -40250.00
NICU.V cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -60149.00
NICU.V cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -60149.00
NICU.V income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 498839.00
NICU.V cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -3000000.00
NICU.V balance_sheet (annual, 2023-12-31) — Net PPE: 17648765.00
NICU.V cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -81773.00
NICU.V balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 24848750.00
NICU.V income_statement (annual, 2023-12-31) — Normalized EBITDA: -9306845.00
NICU.V income_statement (annual, 2023-12-31) — Normalized Income: -9726686.00
NICU.V cash_flow (annual, 2023-12-31) — Operating Cash Flow: -10535734.00
NICU.V income_statement (annual, 2023-12-31) — Operating Income: -12617950.00
NICU.V income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
NICU.V balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 163379860.00
NICU.V balance_sheet (annual, 2023-12-31) — Other Equity Interest: 4413026.00
NICU.V income_statement (annual, 2023-12-31) — Other Gand A: 1297680.00
NICU.V income_statement (annual, 2023-12-31) — Other Income Expense: 2397232.00
NICU.V cash_flow (annual, 2023-12-31) — Other Non Cash Items: -2024806.00
NICU.V balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 699724.00
NICU.V income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2392425.00
NICU.V income_statement (annual, 2023-12-31) — Other Operating Expenses: 7673264.00
NICU.V balance_sheet (annual, 2023-12-31) — Other Payable: 2944597.00
NICU.V balance_sheet (annual, 2023-12-31) — Other Properties: 17677063.00
NICU.V balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 41021.00
NICU.V balance_sheet (annual, 2023-12-31) — Payables: 3771440.00
NICU.V balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 4558423.00
NICU.V balance_sheet (annual, 2023-12-31) — Prepaid Assets: 111310.00
NICU.V income_statement (annual, 2023-12-31) — Pretax Income: -9721879.00
NICU.V cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1784566.00
NICU.V cash_flow (annual, 2023-12-31) — Purchase Of Investment: -40250.00
NICU.V cash_flow (annual, 2023-12-31) — Purchase Of PPE: -81773.00
NICU.V balance_sheet (annual, 2023-12-31) — Receivables: 890107.00
NICU.V income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 62081.00
NICU.V income_statement (annual, 2023-12-31) — Reconciled Depreciation: 62081.00
NICU.V cash_flow (annual, 2023-12-31) — Repayment Of Debt: -60149.00
NICU.V balance_sheet (annual, 2023-12-31) — Retained Earnings: -25348360.00
NICU.V income_statement (annual, 2023-12-31) — Salaries And Wages: 2905301.00
NICU.V cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
NICU.V cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
NICU.V income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 175446.00
NICU.V income_statement (annual, 2023-12-31) — Selling General And Administration: 4378427.00
NICU.V balance_sheet (annual, 2023-12-31) — Share Issued: 163379860.00
NICU.V income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
NICU.V cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1458031.00
NICU.V balance_sheet (annual, 2023-12-31) — Stockholders Equity: 24848750.00
NICU.V balance_sheet (annual, 2023-12-31) — Tangible Book Value: 24848750.00
NICU.V income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
NICU.V income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
NICU.V balance_sheet (annual, 2023-12-31) — Taxes Receivable: 890107.00
NICU.V balance_sheet (annual, 2023-12-31) — Total Assets: 30281215.00
NICU.V balance_sheet (annual, 2023-12-31) — Total Capitalization: 24848750.00
NICU.V balance_sheet (annual, 2023-12-31) — Total Debt: 42054.00
NICU.V balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 24848750.00
NICU.V income_statement (annual, 2023-12-31) — Total Expenses: 12617950.00
NICU.V balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 5432465.00
NICU.V balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 18348489.00
NICU.V balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 845590.00
NICU.V income_statement (annual, 2023-12-31) — Total Unusual Items: 4807.00
NICU.V income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 4807.00
NICU.V balance_sheet (annual, 2023-12-31) — Working Capital: 7345851.00
NICU.V income_statement (quarterly, 2024-09-30) — Basic Average Shares: 169378856.00
NICU.V income_statement (quarterly, 2024-09-30) — Basic EPS: -0.03
NICU.V cash_flow (quarterly, 2024-09-30) — Change In Account Payable: 1734000.00
NICU.V cash_flow (quarterly, 2024-09-30) — Change In Inventory: 0.00
NICU.V cash_flow (quarterly, 2024-09-30) — Change In Payable: 1734000.00
NICU.V cash_flow (quarterly, 2024-09-30) — Depreciation: 25276.00
NICU.V cash_flow (quarterly, 2024-09-30) — Depreciation And Amortization: 25276.00
NICU.V income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 169378856.00
NICU.V income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.03
NICU.V cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 0.00
NICU.V income_statement (quarterly, 2024-09-30) — Interest Income: 66821.00
NICU.V income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: 66821.00
NICU.V cash_flow (quarterly, 2024-09-30) — Interest Paid Supplemental Data: 0.00
NICU.V balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 108917.00
NICU.V cash_flow (quarterly, 2024-09-30) — Net Foreign Currency Exchange Gain Loss: 1000.00
NICU.V balance_sheet (quarterly, 2024-09-30) — Other Payable: 928266.00
NICU.V balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 42341.00
NICU.V income_statement (quarterly, 2024-09-30) — Selling And Marketing Expense: 66968.00
NICU.V income_statement (annual, 2024-12-31) — +Operating Expense: 19484000.00
NICU.V income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Accounts Payable: 1258000.00
NICU.V balance_sheet (annual, 2024-12-31) — Accounts Receivable: 1374000.00
NICU.V balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -200815.00
NICU.V balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 5374000.00
NICU.V balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 5374000.00
NICU.V income_statement (annual, 2024-12-31) — Basic Average Shares: 170766096.00
NICU.V income_statement (annual, 2024-12-31) — Basic EPS: -0.10
NICU.V cash_flow (annual, 2024-12-31) — Beginning Cash Position: 10890000.00
NICU.V cash_flow (annual, 2024-12-31) — Capital Expenditure: -24000.00
NICU.V cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -10294.00
NICU.V balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 46000.00
NICU.V balance_sheet (annual, 2024-12-31) — Capital Stock: 71285000.00
NICU.V balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 17535000.00
NICU.V balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 17535000.00
NICU.V cash_flow (annual, 2024-12-31) — Cash Dividends Paid: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Cash Financial: 17535000.00
NICU.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 24641000.00
NICU.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -186000.00
NICU.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -17810000.00
NICU.V cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1992855.00
NICU.V cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: -1060927.00
NICU.V cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -101615.00
NICU.V cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: 70807.00
NICU.V cash_flow (annual, 2024-12-31) — Change In Receivables: -2138399.00
NICU.V cash_flow (quarterly, 2024-12-31) — Change In Receivables: -621955.00
NICU.V cash_flow (annual, 2024-12-31) — Change In Working Capital: -247159.00
NICU.V cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -1612075.00
NICU.V cash_flow (annual, 2024-12-31) — Changes In Cash: 6645000.00
NICU.V balance_sheet (annual, 2024-12-31) — Common Stock: 71285000.00
NICU.V balance_sheet (annual, 2024-12-31) — Common Stock Equity: 35043000.00
NICU.V cash_flow (annual, 2024-12-31) — Common Stock Issuance: 20333000.00
NICU.V income_statement (annual, 2024-12-31) — Cost Of Revenue: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 2349000.00
NICU.V balance_sheet (annual, 2024-12-31) — Current Assets: 20975000.00
NICU.V balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 36000.00
NICU.V balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 36000.00
NICU.V balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 198000.00
NICU.V balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 0.00
NICU.V balance_sheet (annual, 2024-12-31) — Current Liabilities: 3643000.00
NICU.V cash_flow (annual, 2024-12-31) — Deferred Income Tax: 0.00
NICU.V cash_flow (annual, 2024-12-31) — Deferred Tax: 0.00
NICU.V cash_flow (annual, 2024-12-31) — Depreciation: 83099.00
NICU.V cash_flow (quarterly, 2024-12-31) — Depreciation: 11782.00
NICU.V cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 83000.00